CORBUS PHARMACEUTICALS HOLDI (CRBP) Stock Income Statement
NASDAQ:CRBP - Nasdaq - US21833P3010 - Common Stock - Currency: USD
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 880.00K | |||
| Operating Expenses | 67.04M | 49.00M | 45.00M | 34.84M | 56.87M | |||
| Research and Development | 50.42M | N/A | 31.17M | 16.14M | 36.45M | |||
| Selling, General, and Administrative Expenses | 16.61M | 16.00M | 14.00M | 18.70M | 20.43M | |||
| Operating Income | -67.04M | -49.00M | -45.00M | -34.84M | -55.99M | |||
| Interest Income/Expense | 7.32M | N/A | -2.92M | -2.46M | -1.55M | |||
| Other Income/Expense | 1.76M | 9.00M | 3.39M | -50.00K | 11.90M | |||
| Non Recurring Items | N/A | N/A | 0.00 | -5.00M | N/A | |||
| Income Before Taxes | -57.95M | -40.00M | -45.00M | -42.35M | -45.64M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -57.95M | -40.00M | -45.00M | -42.35M | -45.64M | |||
| EBITDA | -66.61M | -48.41M | -44.36M | -34.08M | -54.99M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.76 | -3.63 | -10.39 | -10.15 | -11.13 | |||
| Non GAAP EPS | -4.76 | -3.66 | -10.15 | -10.41 | -7.64 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | -5186.36% | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | -6362.50% | |||
All data in USD